RxDoctor Payments Data

Peter Samoei

Gerontology · Independence, MONPI 1487241527

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,933 of the $4,453 with a category attached, or 88.3%. 8 manufacturers reported payments, led by Avanir Pharmaceuticals, Inc. at 40.9% of the total. Reporting peaked in 2022 at $1,700 and has fallen 81.8% since, to $309 in 2025. Among gerontology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,453in general payments, 2019–2025

Across 195 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Acadia Pharmaceuticals Inc$677
  • Neurocrine Biosciences, Inc.$486
  • UCB, Inc.$128
  • Sumitomo Pharma America, Inc.$82
  • plus $80 from 2 others

What the payments were for

  • Consulting fees$52012%
  • Food & beverage$3,93388%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,453 in reported general payments places this provider in the 90th percentile of 175 gerontology providers in Missouri.

See all gerontology providers in Missouri

Medicare billing

Part B allowed, 2024
$187,731
Medicare patients
318
Services billed
3,301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf18$5,693
Mirtazapine74$2,237
Midodrine Hcl18$1,749
Potassium Chloride42$1,452
Divalproex Sodium32$1,342
Pantoprazole Sodium17$954
CeftriaxoneCeftriaxone Sodium14$946
Sertraline Hcl43$911
Levothyroxine Sodium25$844
Buspirone Hcl33$677
Gabapentin19$613
Doxycycline Hyclate23$612
Carvedilol28$541
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate20$530
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$529

Paid to pharmacies, not to this prescriber.

Other gerontology in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →